Scribe Biosciences

About Scribe Biosciences

This startup develops single-cell analysis tools utilizing printed droplet microfluidics for picoliter-scale manipulations through fluorescence-activated microfluidic droplet sorting. Their technology enables precise study of infectious cancer diseases, providing critical insights for clinical and research applications.

This startup develops single-cell analysis tools utilizing printed droplet microfluidics for picoliter-scale manipulations through fluorescence-activated microfluidic droplet sorting. Their technology enables precise study of infectious cancer diseases, providing critical insights for clinical and research applications.

What does Scribe Biosciences do?

This startup develops single-cell analysis tools utilizing printed droplet microfluidics for picoliter-scale manipulations through fluorescence-activated microfluidic droplet sorting. Their technology enables precise study of infectious cancer diseases, providing critical insights for clinical and research applications.

Where is Scribe Biosciences located?

Scribe Biosciences is based in San Francisco, United States.

When was Scribe Biosciences founded?

Scribe Biosciences was founded in 2017.

How much funding has Scribe Biosciences raised?

Scribe Biosciences has raised $250.0K.

Location
San Francisco, United States
Founded
2017
Funding
$250.0K
Employees
3 employees
Investors
Formic

Scribe Biosciences

6
Relative Traction Score based on online presence metrics compared to companies in the same age group.

Executive Summary

This startup develops single-cell analysis tools utilizing printed droplet microfluidics for picoliter-scale manipulations through fluorescence-activated microfluidic droplet sorting. Their technology enables precise study of infectious cancer diseases, providing critical insights for clinical and research applications.

scribebiosciences.com300+
Founded 2017 – San Francisco, United States

Funding

No specific funding rounds found.

Total Funding

$250.0K

Backed by

BioTools InnovatorFormic

Team (<5)

No team information available.

Company Description

This startup develops single-cell analysis tools utilizing printed droplet microfluidics for picoliter-scale manipulations through fluorescence-activated microfluidic droplet sorting. Their technology enables precise study of infectious cancer diseases, providing critical insights for clinical and research applications.

Sources:

1
This profile is AI-generated from web data and may contain inaccuracies. Want to correct or remove an entry? Owners can claim edits via their company email domain, and signed-in users can submit sourced suggestions.